Skip to content
Menu

Barclays Maintains Equal-Weight on Astrana Health, Raises Price Target to $37

Benzinga Newsdesk 6 months ago

NewsPrice TargetAnalyst Ratings

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Equal-Weight and raises the price target from $26 to $37.

Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Equal-Weight and raises the price target from $26 to $37.

Read at benzinga.com